|Slideshows|June 21, 2019
FDA approvals you might have missed
Author(s)Miranda Hester
A look at 5 recent approvals from the US Food and Drug Administration (FDA), including treatment for systemic lupus erythematosus, a new gene therapy, and pain relief for patients with irritable bowel syndrome.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Vaccine schedule overhaul raises concerns about delayed protection and access, says Ravi Jhaveri, MD
2
Rethinking screen time for back to school
3
Building trust may be key to vaccine conversations with hesitant families
4
Eczema, delayed allergen introduction, and early antibiotics top list of childhood food allergy risk factors
5